Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 376 (LINC00376)
- Target
- LINC00376
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 376 (LINC00376) is a member of the long intergenic non-coding RNA (lincRNA) family, defined as autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap protein-coding genes[3][7][1]. While the general class of lincRNAs can function in chromatin remodeling, transcriptional regulation, maintaining genome architecture, RNA stabilization, and gene expression fine-tuning with high tissue specificity, specific biological or pathological roles for LINC00376 itself have not been robustly documented in the literature as of the current reporting[1][3][7]. No evidence currently supports LINC00376 as a direct pharmaceutical or therapeutic target, nor as a clinically established biomarker or disease gene.
- Other names
- RP11-527N12.1LINC00376
02
Mechanism of action
Not applicable (no therapeutic targeting or direct mechanism defined)
03
Biological functions
Chromatin remodelingRegulation of transcriptionGenome architecture maintenanceRNA stabilizationFine-tuning expression of neighboring genes with tissue specificityPotential enhancer-associated regulatory activity
04
Disease associations
Other (as a class, some lincRNAs are involved in cancer, neurodegeneration, and development[3][7], but there is no specific disease implication for LINC00376 reported in current gene card or reviews)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 376 (LINC00376).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 376 (LINC00376).